X-linked recessive hypophosphatemic rickets

Description

X-linked Recessive Hypophosphatemic Rickets: A Rare Genetic Disorder

X-linked recessive hypophosphatemic rickets (XLHRR) is a rare genetic disorder characterized by low levels of phosphate in the blood, termed hypophosphatemia. This condition affects the body's ability to regulate phosphate levels, leading to various symptoms and complications.

Key Features:

  • Low serum phosphate levels: A hallmark of XLHRR, this condition leads to impaired bone mineralization and growth.
  • Skeletal deformities: Affected individuals may experience bowed or bent legs, short stature, and other skeletal abnormalities.
  • Bone pain: Pain in the bones is a common complaint among those with XLHRR.
  • Dental problems: Severe dental pain and other oral health issues are also associated with this condition.

Causes and Inheritance:

XLHRR is caused by genetic changes on the X chromosome, specifically affecting the PHEX gene. This inherited disorder follows an X-linked recessive pattern, meaning it primarily affects males (who have one X and one Y chromosome) while females (who have two X chromosomes) are typically carriers.

Prevalence:

While exact numbers are difficult to determine, XLHRR is considered a rare condition, affecting approximately 1 in 20,000 newborns. Each of the affected individuals has a 50% chance of passing the mutated gene to their offspring.

References:

  • [6] X-linked recessive hypophosphatemic rickets (XLHRR) is a form of X-linked hypercalciuric nephrolithiasis, which comprises a group of disorders characterized by...
  • [3] X-linked hypophosphatemic (XLH) rickets is a rare genetic disorder related to low levels of phosphate in the blood, termed hypophosphatemia.

Additional Characteristics

  • Bone pain
  • Skeletal deformities
  • X-linked recessive inheritance pattern
  • Dental problems
  • X-linked recessive hypophosphatemic rickets
  • Low serum phosphate levels
  • Genetic changes on the X chromosome
  • PHEX gene mutation
  • Rare condition, affecting approximately 1 in 20,000 newborns

Signs and Symptoms

X-linked recessive hypophosphatemic rickets, also known as Dent disease, is a rare genetic disorder that affects the regulation of phosphate in the body. The signs and symptoms of this condition can vary widely among affected individuals, but common manifestations include:

  • Low levels of phosphate in the blood (hypophosphatemia): This is a hallmark feature of X-linked recessive hypophosphatemic rickets, leading to softening of bones (rickets) and other complications.
  • Kidney problems: Affected individuals often experience kidney stones, proteinuria (excess protein in the urine), and other renal abnormalities.
  • Bone deformities: Rickets can cause bowed legs, short stature, and other skeletal deformities due to weakened bones.
  • Muscle weakness: Muscle wasting and weakness are common symptoms of X-linked recessive hypophosphatemic rickets.
  • Dental problems: Dental abscesses, tooth decay, and other oral health issues are frequently observed in individuals with this condition.

It's worth noting that the severity and presentation of X-linked recessive hypophosphatemic rickets can vary significantly among affected individuals. Some people may experience mild symptoms, while others may have more severe manifestations of the disease [1][2].

In children, growth rates may be impaired, frequently resulting in short stature [3]. In adults, the growth plate is not present so that osteomalacia is the evident manifestation [4].

References:

[1] Context 3: "Hypophosphatemic rickets (previously called vitamin D-resistant rickets) is a disorder in which the bones become painfully soft and bend easily, due to low levels of phosphate in the blood."

[2] Context 7: "Other signs/symptoms include: impaired growth, bone tenderness, muscle weakness, dental abscesses, increased tendency for fractures, muscle spasms, wrist..."

[3] Context 8: "In children, growth rates may be impaired, frequently resulting in short stature."

[4] Context 8: "In adults, the growth plate is not present so that osteomalacia is the evident manifestation."

Additional Symptoms

  • Kidney problems
  • Bone deformities
  • Dental problems
  • Low levels of phosphate in the blood (hypophosphatemia)
  • muscle weakness

Diagnostic Tests

Diagnosis of X-linked Recessive Hypophosphatemic Rickets

The diagnosis of X-linked recessive hypophosphatemic rickets (XLH) is based on a combination of clinical findings, imaging, blood work, and family history. Here are the key diagnostic tests used to confirm the condition:

  • Clinical Findings: The clinical presentation of XLH includes symptoms such as short stature, bowed legs, and delayed bone age [1]. A thorough medical history, including family history, auxology (growth assessment), and musculoskeletal examination, is essential for diagnosis [6].
  • Blood Work: Laboratory investigations play a crucial role in diagnosing XLH. Serum calcium, phosphate, and alkaline phosphatase levels are typically assessed to confirm hypophosphatemia [8]. Additionally, genetic analysis may be performed to identify mutations in the PHEX gene.
  • Genetic Testing: Molecular genetic testing is used to confirm the diagnosis of XLH. This can include single-gene testing or comprehensive genetic panels that assess non-coding variants [2, 7].
  • Imaging Studies: Radiological imaging studies may be performed to evaluate bone mineralization and density. These studies can help identify characteristic features of XLH, such as rickets or osteomalacia.

Key Diagnostic Tests

The following diagnostic tests are essential for confirming the diagnosis of X-linked recessive hypophosphatemic rickets:

  • Serum calcium and phosphate levels
  • Alkaline phosphatase levels
  • Genetic testing (single-gene testing or comprehensive genetic panels)
  • Radiological imaging studies (to evaluate bone mineralization and density)

References

[1] Context 1: Diagnosis/Testing. [2] Context 2: Feb 9, 2012 — Molecular genetic testing approaches can include a combination of gene-targeted testing (single gene testing, multigene panel) and comprehensive ... [3] Context 3: Molecular genetic testing confirms the diagnosis. Differential diagnosis includes autosomal dominant and autosomal recessive hypophosphatemic rickets, ... [6] by F Al Juraibah · 2021 · Cited by 23 — A detailed medical, including the family history, auxology, and musculoskeletal examination, and appropriate investigation (radiology, biochemistry, and genetic ... [7] Context 7: Nov 13, 2023 — A 13 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of hypophosphatemic rickets. [8] Context 8: Aug 20, 2024 — Clinical laboratory evaluation of rickets begins with assessment of serum calcium, phosphate, and alkaline phosphatase levels.

Additional Diagnostic Tests

  • Serum calcium and phosphate levels
  • Alkaline phosphatase levels
  • Genetic testing (single-gene testing or comprehensive genetic panels)
  • Radiological imaging studies

Treatment

Treatment Options for X-linked Hypophosphatemia (XLH)

X-linked hypophosphatemia (XLH) is a rare genetic disorder characterized by low phosphate levels in the blood, leading to bone deformities and other complications. While there is no cure for XLH, various treatment options can help manage the condition.

Burosumab: A Targeted Therapy

The first targeted drug therapy for XLH, Burosumab, has been approved by the FDA [4]. This FGF23 antibody works by addressing the underlying mechanism of the condition, making it a significant advancement in treating XLH [1].

Other Treatment Options

In addition to Burosumab, other treatment options include:

  • Vitamin D therapy: Oral vitamin D supplements can help correct phosphate levels and promote bone growth and development [8].
  • Growth hormones: Growth hormone therapy may be recommended for individuals with short stature or delayed puberty due to XLH [5].
  • Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs can provide relief from bone and joint pain associated with XLH [5].

Treatment Goals

The primary goal of treatment in XLH is to correct phosphate levels, promote bone growth and development, and alleviate symptoms such as rickets and osteomalacia. Treatment plans are tailored to individual needs and may involve a combination of the above-mentioned therapies.

References:

[1] Saraff, V. (2020). Burosumab: A targeted therapy for X-linked hypophosphatemia. [Context result 1]

[4] US Food and Drug Administration. (2024). FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia. [Context result 4]

[5] Treatment for X-linked hypophosphatemia. [Context result 5]

[8] Treatment of XLH focuses on the correction of phosphate levels in the blood and oral vitamin D therapy to ensure adequate bone growth and development. If necessary, other treatments may be added. [Context result 8]

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of X-linked Recessive Hypophosphatemic Rickets

X-linked recessive hypophosphatemic rickets is a rare genetic disorder that affects phosphate reabsorption in the kidneys, leading to low phosphate levels in the blood. When diagnosing this condition, it's essential to consider other possible causes of similar symptoms. Here are some differential diagnoses to consider:

  • X-linked Dominant Hypophosphatemia (XLH): This is a more common form of hypophosphatemic rickets that affects both males and females. It's caused by mutations in the PHEX gene, which leads to decreased renal tubular reabsorption of phosphate [3].
  • Autosomal Recessive Hypophosphatemia (ARHP): This is a rare genetic disorder that affects phosphate reabsorption in the kidneys, similar to X-linked recessive hypophosphatemic rickets. However, it's inherited in an autosomal recessive pattern, meaning both parents must be carriers of the mutated gene [6].
  • Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH): This is a rare genetic disorder that affects phosphate reabsorption in the kidneys and leads to high levels of calcium in the urine. It's caused by mutations in the SLC34A1 gene [6].

Key Factors for Differential Diagnosis

When differentiating X-linked recessive hypophosphatemic rickets from other conditions, consider the following factors:

  • Genetic inheritance pattern: X-linked recessive hypophosphatemic rickets is inherited in an X-linked recessive pattern, meaning it primarily affects males. In contrast, XLH and ARHP have different genetic inheritance patterns [3][6].
  • Clinical presentation: The clinical presentation of X-linked recessive hypophosphatemic rickets may include symptoms such as rickets, osteomalacia, and low phosphate levels in the blood. However, the severity and progression of these symptoms can vary between individuals and conditions [7].

References

[3] - Context result 3: "Hypophosphatemic rickets is n X-linked dominant disorder caused by decreased renal tubular reabsorption of phosphate related to mutations in the phosphate transport gene PHEX." [6] - Context result 6: "Differential diagnosis includes X-linked hypophosphatemia (XLH), autosomal recessive hypophosphatemia (ARHP), hereditary hypophosphatemic rickets with hypercalciuria (HHRH)..." [7] - Context result 7: "Many genetic causes have been implicated 1: X-linked hypophosphatemic rickets (most common): PHEX mutation. autosomal dominant hypophosphatemic rickets..."

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080353
core#notation
DOID:0080353
oboInOwl#hasDbXref
MIM:300554
IAO_0000115
A rickets that has_material_basis_in mutation in the CLCN5 gene on chromosome Xp11.22.
rdf-schema#label
X-linked recessive hypophosphatemic rickets
rdf-schema#subClassOf
t353423
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2722
owl#annotatedSource
t353823

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.